M&A Deal Summary

Rockcliffe Labs Acquires Algae-C

On October 2, 2025, Rockcliffe Labs acquired life science company Algae-C

Acquisition Highlights
  • This is Rockcliffe Labs’ 1st transaction in the Life Science sector.
  • This is Rockcliffe Labs’ 1st transaction in Canada.
  • This is Rockcliffe Labs’ 1st transaction in Ontario.

M&A Deal Summary

Date 2025-10-02
Target Algae-C
Sector Life Science
Buyer(s) Rockcliffe Labs
Deal Type Add-on Acquisition

Target

Algae-C

Ontario, Canada
Algae-C is a biotechnology company dedicated to algae-based molecular discovery and production. Its proprietary technology enables scalable, sustainable production of high-value compounds with applications in health, wellness, and advanced materials. Algae-C is based in Ontario.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Rockcliffe Labs

Montreal, Quebec, Canada

Category Company
Sector Life Science
DESCRIPTION

Rockcliffe Labs is a Canadian biotechnology venture creation platform that integrates academic discovery with clinical, regulatory, and capital markets expertise. It builds diversified multi-asset pipelines spanning pharmaceuticals, diagnostics, and bio-based technologies. Rockcliffe Labs is based in Montreal, Quebec.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Ontario M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2025 M&A 1 of 1